Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
Status:
Completed
Trial end date:
2011-07-15
Target enrollment:
Participant gender:
Summary
To investigate the effect and safety of intracoronary autologous bone morrow mesenchymal stem
cells (BM-MSCs) transplantation in patients with ST-segment elevation myocardial infarction（
STEMI） .
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Affiliated Hospital of North Sichuan Medical College
Collaborators:
Beijing Tongren Hospital Chinese PLA General Hospital Peking Union Medical College Hospital